Cargando…

Is immunotherapy here to stay in multiple myeloma?

Immune escape and impaired immune surveillance have been identified as emerging hallmarks of cancer.(1) Multiple myeloma represents a genuine example of disrupted immune surveillance characterized by: impaired antibody production, deregulation of the T and natural killer cell compartment, disruption...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodríguez-Otero, Paula, Paiva, Bruno, Engelhardt, Monika, Prósper, Felipe, San Miguel, Jesús F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ferrata Storti Foundation 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394971/ https://www.ncbi.nlm.nih.gov/pubmed/28082344 http://dx.doi.org/10.3324/haematol.2016.152504

Ejemplares similares

CAR T-Cells in Multiple Myeloma Are Ready for Prime Time
por: Rodríguez-Otero, Paula, et al.
Publicado: (2020)

CXCR3: Here to stay to enhance cancer immunotherapy?
por: Rogava, Meri, et al.
Publicado: (2019)

Immune checkpoint inhibitors: here to stay
por: Carvalho, Filomena Marino, et al.
Publicado: (2023)

Is Telehealth Here to Stay?
por: Gardenier, Donald, et al.
Publicado: (2021)

The deacetylase inhibitors—here to stay!
por: Prince, H. Miles
Publicado: (2010)

Preprints with The Lancet are here to stay
por: Kleinert, Sabine, et al.
Publicado: (2020)

SARS may be here to stay
por: Pilcher, Helen R.
Publicado: (2003)

Here to Stay: Biosimilars in Hematology
por: Gribben, John, et al.
Publicado: (2019)

Measurable residual disease in multiple myeloma: ready for clinical practice?
por: Burgos, Leire, et al.
Publicado: (2020)

The implantable loop recorder: A tool that is "here to stay"
por: Cock, Carel C
Publicado: (2002)

Sex Differences Are Here to Stay: Relevance to Prenatal Care
por: Inkster, Amy M., et al.
Publicado: (2021)

P951: IMPACT OF MEASURABLE RESIDUAL DISEASE (MRD) DIFFERENCES ON PROGRESSION-FREE SURVIVAL (PFS): AN AGGREGATE DATA ANALYSIS FROM RANDOMIZED CLINICAL TRIALS IN MULTIPLE MYELOMA (MM)
por: Paiva, Bruno, et al.
Publicado: (2023)

Nephron sparing surgery: Is here to stay
por: Gopalakrishnan, Ganesh
Publicado: (2007)

Is EUS Here to Stay? Accuracy Is Not an Indication…
por: Sahai, Anand V.
Publicado: (2012)

Is Femto cataract surgery here to stay?
por: Al-Saleh, Ahmed A.
Publicado: (2015)

Laparoscopic renal surgery is here to stay
por: Luk, Angus Chin On, et al.
Publicado: (2018)

Are telephone consultations here to stay in rheumatology?
por: Raizada, Sabrina R, et al.
Publicado: (2020)

Virtual Mega-Meetings: Here to Stay?
por: Hassell, Lewis A., et al.
Publicado: (2021)

Immunotherapy for Multiple Myeloma
por: Tamura, Hideto, et al.
Publicado: (2019)

Immunotherapy in Multiple Myeloma
por: Soekojo, Cinnie Yentia, et al.
Publicado: (2020)

Biological Characterization and Clinical Relevance of Circulating Tumor Cells: Opening the Pandora’s Box of Multiple Myeloma
por: Garcés, Juan-José, et al.
Publicado: (2022)

Deficient Spindle Assembly Checkpoint in Multiple Myeloma
por: Díaz-Rodríguez, Elena, et al.
Publicado: (2011)

The term “pregnancy of unknown location” is here to stay
por: Condous, George, et al.
Publicado: (2015)

Mechanical prosthetic heart valves: here to stay!
por: Kassou, Sofia, et al.
Publicado: (2018)

15. Zirconia implants : mainstay or here to stay?
por: Dubey, Mridu
Publicado: (2018)

With Risk of Reinfection, Is COVID-19 Here to Stay?
por: Jabbari, Parnian, et al.
Publicado: (2020)

Religious Values in Clinical Practice are Here to Stay
por: Kørup, Alex Kappel, et al.
Publicado: (2018)

COVID Will End But Telemedicine May be Here to Stay
por: Krueger, C.A., et al.
Publicado: (2021)

Cannabinoid hyperemesis syndrome: the conundrum is here to stay
por: Schey, Ron
Publicado: (2020)

Virtual Reality: Hybrid Interviews Are Here to Stay
por: Cooper, Avraham Z., et al.
Publicado: (2022)

Keeping Myeloma in Check: The Past, Present and Future of Immunotherapy in Multiple Myeloma
por: Ackley, James, et al.
Publicado: (2021)

The Role of Immunotherapy in Multiple Myeloma
por: Kocoglu, Mehmet, et al.
Publicado: (2016)

Cellular immunotherapy in multiple myeloma
por: Vo, Manh-Cuong, et al.
Publicado: (2019)

Allogeneic Stem Cell Transplantation in Multiple Myeloma
por: Greil, Christine, et al.
Publicado: (2021)

Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma
por: Larrayoz, Marta, et al.
Publicado: (2023)

Data-Driven Dental, Oral, and Craniofacial Analytics: Here to Stay
por: Schwendicke, F., et al.
Publicado: (2022)

Retroclavicular approach of brachial plexus block: Here to stay!!!
por: Sinha, Chandni, et al.
Publicado: (2017)

ICU Cornerstone: High frequency ventilation is here to stay
por: Rimensberger, Peter C
Publicado: (2003)

Beta-blocking agents in cardiovascular disease; are they here to stay?
por: van der Wall, E. E.
Publicado: (2014)

Modern Inflammatory Phenotyping of Asthma. Breathomics Is Here to Stay
por: Sterk, Peter J.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4bd1401tsl2ekuojnvr1uuuuo7